Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
What should marketing and medical affairs invest in for Q4?
Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024 and what teams should leverage in Q4.
Read more
Top tips for digital innovation and the future of patient centricity
Helena is joined by well-known pharma conference speaker Konrad Dobschuetz to discuss his top tips for digital innovation in the pharma industry.
Medical affairs, commercial and enhancing soft skills
In this episode, Helena hosts a medical affairs discussion with Novartis UK’s Samin Saeed about leadership, company culture, soft skills development and much more.
Pharmacovigilance past, present and future
Marc and Helena are joined by Pav Rishiraj, Director and Head of Pharmacovigilance, Ipsen, to shed light on this often-overlooked field.
Meet GOLD’s new catalyst – medical aficionado Juby Jacob-Nara
An exclusive version of our conversation Juby Jacob-Nara (Sanofi) about how former physicians can empower themselves to succeed in the pharmaceutical industry.
Season finale: MMR and vaccines past, present and future
As Helena and Marc wrap up this season, they’re joined by Mike Watson, CEO of Mevox, to discuss past present and future of vaccines.
Key pharma trends from Cannes Lions
In this episode, Helena and Marc are joined by Claire Gillis, CEO, VMLY&R Health, to discuss the health and pharma highlights from the recent Cannes Lions.
Big pharma vs biotech and the future of marketing
Helena and Marc are joined by Michele Manto, CCO, Galapagos, and Robert Grimm, Digital Marketing and Transformation Manager, Novo Nordisk.
Meet GOLD's recent catalyst – Claus Zieler
In this episode, Helena and Marc are joined by Claus Zieler, President of Established Markets, Astellas, to discuss leadership and crisis management.
Loading posts...
« Previous
1
…
7
8
9
10
11
…
23
Next »